Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02688296 · ClinicalTrials.gov registry record
Effectiveness Of The Fibulock Intramedullary Nail
A clinical trial, sponsored by Arthrex.
- Completed
- Registry status
- 34
- Enrollment target
NCT02688296: Completed study, sponsored by Arthrex.
NCT02688296 is a clinical trial that has completed, run by Arthrex. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02688296 has completed, sponsored by Arthrex.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The objective of this post-market clinical study is to evaluate efficacy outcomes and complication rates in patients who have received the Fibulock™ Intramedullary Nail.
Primary Outcome
Lateral and mortice view x-rays at 26 weeks
Interventions
- DEVICE Fibulock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2016-05-24 |
| Est. Completion | 2020-07-09 |
What the finished NCT02688296 record still lists
NCT02688296 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fibulock is the first listed.
NCT02688296 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02688296 about?
NCT02688296 is a clinical study titled "Effectiveness Of The Fibulock Intramedullary Nail". The objective of this post-market clinical study is to evaluate efficacy outcomes and complication rates in patients who have received the Fibulock™ Intramedullary Nail.
What is the current status of trial NCT02688296?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2016-05-24. Estimated completion is 2020-07-09.
What interventions are being tested in trial NCT02688296?
The interventions under investigation include: Fibulock (DEVICE).
Who is sponsoring clinical trial NCT02688296?
This trial is sponsored by Arthrex, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI